MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Management practices and long-term follow up of pediatric functional (psychogenic) movement disorder at a tertiary care center

    M. Hull, J.M Maldonado-Duran, M. Parnes (Houston, TX, USA)

    Objective: We evaluated management practices and compared efficacy of specific interventions on remission of symptoms of functional movement disorder (FMD) in our pediatric population. Background: Current recommendations of managing FMD revolve…
  • MDS Virtual Congress 2020

    Utility of VMAT2 inhibitors in management of stereotypy in children: a series of six patients

    M. Hull, M. Parnes (Houston, TX, USA)

    Objective: We aim to evaluate the effectiveness of VMAT2 inhibitors in the treatment of stereotypy. Background: Stereotypies are continual, rhythmic, patterned movements that can occur  in typically-developing children, and are…
  • MDS Virtual Congress 2020

    Kinematic control in children with essential tremor

    A. Medina Escobar, N. Cothros, R. Hawe, D. Martino, S. Dukelow, A. Kirton, E. Roze, E. Nosratmirshekarlou, T. Pringsheim (Calgary, AB, Canada)

    Objective: We aim to explore motor control in children with essential tremor (ET) utilizing the Kinarm exoskeleton robot. Background: Tremor is one of the most…
  • MDS Virtual Congress 2020

    Diverse Phenotypic Variations Among Siblings with NBIA: A Case Report and Review of Literature

    N. Merghany, A. Al Hasany (Cairo, Egypt)

    Objective: The purpose of this case report and  literature review  is to increase the awareness of  practicing clinicians regarding  the mosaic clinical pattern this disease…
  • MDS Virtual Congress 2020

    Inter-relation between hand functioning, cognition and quality of life of CP children: 2-year prospective randomized study

    T. Voloshyn, V. Kozyavkin, L. Shestopalova (Truskavets, Ukraine)

    Objective: For treatment of CP patients multidisciplinary approach is often promoted. But it is not cost-efficient to involve all medical staff and use wide variety…
  • MDS Virtual Congress 2020

    Phenotyping spasticity-associated tonic spasms: implications for therapy

    H. Abboud, S. Saad, M. Elkasaby, C. Kilbane (Cleveland, OH, USA)

    Objective: To evaluate common phenotypes of tonic spasms (TS) in patients with spasticity and inform therapeutic interventions. Background: Spasticity can be associated with several hyperkinetic…
  • MDS Virtual Congress 2020

    Does “5-2-1” identify patients with suspected Advanced Parkinson’s Disease? Evidence of clinical accuracy from G7 countries

    A. Antonini, P. Odin, T. Henriksen, M. Soileau, R. Rodriguez-Cruz, A. Alobaidi, Y. Jalundhwala, P. Kandukuri, J.C Parra, K. Onuk, P. Kukreja, A. Gillespie, J. Pike, K.R Chaudhuri (North Chicago, IL, USA)

    Objective: Evaluate the psychometric properties of (i) the “5-2-1” criteria and (ii) consensus-driven clinical indicators of suspected advanced Parkinson’s disease (APD). Background: Recent consensus panel…
  • MDS Virtual Congress 2020

    Psychometric properties of clinical indicators of device-aided therapy eligibility among Parkinson’s disease patients: Real-world data from 6 countries

    K. Chaudhuri, R. Pahwa, S. Isaacson, A. Merola, A. Alobaidi, P. Kandukuri, J.C Parra, L. Bergmann, E. Jones, A. Antonini (London, United Kingdom)

    Objective: Evaluate the performance of clinical indicators for Device-aided Therapy (DAT) eligibility in real-world setting. Background: Timely initiation of appropriate DAT may improve quality of…
  • MDS Virtual Congress 2020

    Simultaneous, levodopa-responsive Holmes’ tremor and hemiparkinsonism due to midbrain cavernous malformation

    A. Dessy, P. Drummond (New York, NY, USA)

    Objective: We report a case of concomitant Holmes’ tremor (HT) and hemiparkinsonism (HP) attributable to a single structural lesion with robust clinical response to levodopa.…
  • MDS Virtual Congress 2020

    Effects of Different Side-of-onset on Symptoms, Progression, and Prognosis in Parkinson’s Disease

    X. Huang, Y. Huang, C. Liu, X. Huang, Y. Zhang, Q. Ye (Fuzhou, China)

    Objective: We conducted an ambispective cohort study, with the largest number of involved patients for now, to assess whether the different side-of-onset could affect the…
  • « Previous Page
  • 1
  • …
  • 662
  • 663
  • 664
  • 665
  • 666
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley